EIF2A and neoplasm: In addition, oral administration of 6-Shogao suppressed the pro-survival pathway of p-PERK, eIF2a and p-eIF2α while it increased the cleavage of caspase-3, leading to reduction in SMMC-7721 tumor xenografts model [159].